医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| L-叔亮氨酸叔丁酯盐酸盐 | (S)-tert-butyl 2-amino-3,3-dimethylbutanoate hydrochloride | 119483-45-3 | C10H21NO2*ClH |
| L-丙氨酸苄酯对甲苯磺酸盐 | L-alanine benzyl ester p-toluenesulfonate | 42854-62-6 | C7H8O3S*C10H13NO2 |
| L-丙交酯 | L,L-dilactide | 4511-42-6 | C6H8O4 |
| L-䓝基乙醛酸酯水合物 | L-menthyl glyoxylate monohydrate | 111969-64-3 | C12H22O4 |
| L-n-丁基磺酰基-p-羟基苯基丙氨酸 | N-(butanesulfonyl)-L-tyrosine | 149490-60-8 | C13H19NO5S |
| L-5-甲基四氢叶酸氨基葡萄糖盐 | Levomefolate glucosamine | 1181972-37-1 | C32H51N9O16 |
| L-5-甲基四氢叶酸 | 5-methyl-(6S)-tetrahydrofolic acid | 31690-09-2 | C20H25N7O6 |
| L-4-氰基苯丙氨酸 | 6-bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | 337463-88-4 | C7H5BrN2O2 |
| L-3-碘-4-羟基苯甘氨酸 | (S)-2-amino-2-(4-hydroxy-3-iodophenyl)acetic acid | 1208237-78-8 | C8H8INO3 |
| L(+)-2-氨基-4-溴丁酸氢溴酸盐 | (2S)-2-amino-4-bromobutanoic acid hydrobromide | 15159-65-6 | BrH*C4H8BrNO2 |
| JNJ 3026582; 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 | RWJ67657 | 215303-72-3 | C27H24FN3O |
| IS(+)-3-溴樟脑-10-磺酸 | ((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | 206860-46-0 | C10H17BrO5S |
| IN1861,1,2-双(5-(三甲基锡基)噻吩-2-基)乙炔 | 1,2-bis(5-(trimethylstannyl)thiophen-2-yl)ethyne | 1610057-24-3 | C16H22S2Sn2 |
| IN1579,(E)-2,3-二(5-溴噻吩-2-基)丙烯腈 | (E)-2,3-bis(5-bromothiophen-2-yl)acrylonitrile | 439588-79-1 | C11H5Br2NS2 |
| HM30181甲磺酸盐 | N-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1H)- isoquinolinyl)ethyl]phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4H-chromene-2-carboxamide mesylate | 849675-87-2 | CH4O3S*C38H36N6O7 |
| GSK789472盐酸盐 | 1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride | 1257326-24-1 | C15H22ClN3O |
| GLPG-0634 中间体 | N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | 1142943-96-1 | C10H9BrN4O |
| Fmoc-保护氨基酸 | L-3-acetyl-amino-2-Fmoc-amino-propionic acid | 181952-29-4 | C20H20N2O5 |
| Fmoc-3-(2-喹啉基)-DL-Ala-OH | Fmoc-3-(2-quinolyl)-DL-alanine | 401514-70-3 | C27H22N2O4 |
| FMOC-L-Alpha-氨基己二酸-δ-t-丁酯 | Fmoc-Aad(O-t-Bu)-OH | 159751-47-0 | C25H29NO6 |
| ETHYL 5-硝基-2-吡啶乙基甲苯 | ethyl 5-nitropicolinate | 30563-98-5 | C8H8N2O4 |
| Dolutegravir中间体 | 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1335210-23-5 | C13H17NO8 |
| DolutegravirDL5A中间体 | 2,5-dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate | 1357289-08-7 | C20H23NO8 |
| DURLOBACTAM钠盐 | ETX2514 | 1467157-21-6 | C8H10N3O6S*Na |
| DL-哌酸-d9 | D,L-[2,3,3,4,4,5,5,6,6-d9]pipecolic acid | 790612-94-1 | C6H11NO2 |
| DL-去甲肾上腺素 | Norepinephrine | 138-65-8 | C8H11NO3 |
| DL-二氢玉米素 | dihydrozeatin | 23599-75-9 | C10H15N5O |
| DL-乳酸伏硫西汀 | 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine DL-lactate | 1253056-29-9 | C3H6O3*C18H22N2S |
| DL-3,4-二羟基扁桃酸 | 3,4-dihydroxymandelic acid | 775-01-9 | C8H8O5 |
| DL-2-氨基-4-戊烯酸 | Allylglycine | 7685-44-1 | C5H9NO2 |
| DBCO-酸 | 4-(11,12-didehydrodibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid | 1353016-70-2 | C19H15NO3 |
| D-麦角酸甲酯 | (+/-)-methyl lysergate | 4579-64-0 | C17H18N2O2 |
| D-萤光素乙酯 | d-Luciferin, ethyl ester | 135251-85-3 | C13H12N2O3S2 |
| D-哌啶-2-甲酸 | (R)-(+)-pipecolic acid | 1723-00-8 | C6H11NO2 |
| D-古洛糖酸 | gluconic acid | 20246-53-1 | C6H12O7 |
| D-伐昔洛韦盐酸盐 | D-Valacyclovir Hydrochloride | 124832-28-6 | C13H21ClN6O4 |
| D-7-羟基-1,2,3,4-四氢异喹啉-3-甲酸 | (3R)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 152286-30-1 | C10H11NO3 |
| D-3-(3-苯并噻吩基)丙氨酸 | (R)-2-amino-3-<1>benzothiophene-3-ylpropionic acid | 111139-55-0 | C11H11NO2S |
| D-(-)-酒石酸二乙酯 | diethyl (2S,3S)-tartrate | 57968-71-5 | C8H14O6 |
| D-(-)-4-乙基-2,3-二氧-1-哌嗪酰胺基对羟基苯乙酸 | D-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonylamino]-2-(4-hydroxyphenyl)-acetic acid | 79868-75-0 | C15H17N3O6 |
| D-(+)-2-(4-苯基哌啶基)环己醇盐酸盐 | (+)-Vesamicol | 112709-60-1 | C17H25NO |
| D,L-4-咪唑基甘氨酸 | D,L-4-imidazolylglycine | 13726-60-8 | C5H7N3O2 |
| CAL-101(N-2)中间体 | tert-butyl (S)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate | 870281-85-9 | C22H24FN3O3 |
| C-(5-氯-吡嗪-2-基)-甲胺 | (5-chloropyrazin-2-yl)methanamine | 1060814-53-0 | C5H6ClN3 |
| C-(2-甲氧基-吡啶-3-基)-甲胺 | (2-methoxypyridin-3-yl)methanamine | 354824-19-4 | C7H10N2O |
| Bz-L-丙氨酸-βNA | Benzoyl-L-alanine beta-naphthylamide | 201988-47-8 | C20H18N2O2 |
| Boc-顺式-3-羟基-L-脯氨酸 | (2S,3R)-1-(tert-butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid | 186132-96-7 | C10H17NO5 |
| Boc-Val-氯甲基酮 | Boc-Val-CH2Cl | 103542-47-8 | C11H20ClNO3 |
| Boc-(s)-3-氨基-2-苯丙酸 | N-Boc-phenylpropanoic acid | 136916-26-2 | C14H19NO4 |
| Boc-(S)-3-氨基-3-(1-萘基)-丙酸 | (S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid | 500770-68-3 | C18H21NO4 |